After 8 months of taking the wrong medication, Miss G developed a rash. Her mother took her to the emergency department (ED) ...

The lawsuit was prompted by several recent HHS actions the plaintiffs noted were “designed to mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric.” ...

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

Percentage increase in estimated mean annual HTN deaths from excessive alcohol use higher among women than men.

Products containing synthetic dyes have 141 percent higher mean total sugar, lower levels of sodium, saturated fat.

HealthDay News — There has been nationwide total of 1267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak, the US Centers for Disease Control and ...

National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3% by 2033.

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.

The Food and Drug Administration (FDA) has granted accelerated approval to Lynozyfic™ (linvoseltamab-gcpt) for the treatment of adult patients with ...

We spoke with Dr Kellan Baker of the Whitman-Walker institute to shed some light on the many changes taking place to various aspects of medical care for LGBTQ+ individuals.